Vyome Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HIND research report →
Companywww.vyometx.com
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
- CEO
- Venkateswarlu Nelabhotla
- IPO
- 2016
- Employees
- 18
- HQ
- Princeton, NJ, US
Price Chart
Valuation
- Market Cap
- $11.88M
- P/E
- -0.94
- P/S
- 8.83
- P/B
- 1.85
- EV/EBITDA
- -0.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.16%
- Op Margin
- -401.91%
- Net Margin
- -985.46%
- ROE
- -302.13%
- ROIC
- -67.02%
Growth & Income
- Revenue
- $319.71K · -96.01%
- Net Income
- $-10,262,007 · -43.93%
- EPS
- $-4.75 · 98.63%
- Op Income
- $-2,747,037
- FCF YoY
- 15.32%
Performance & Tape
- 52W High
- $33.16
- 52W Low
- $1.75
- 50D MA
- $2.17
- 200D MA
- $4.55
- Beta
- 1.39
- Avg Volume
- 44.59K
Get TickerSpark's AI analysis on HIND
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 25 | Pomichter Stanley D III | other | 17,833 |
| Aug 15, 25 | Pomichter Stanley D III | other | 0 |
| Aug 15, 25 | Jolly Mohanjit | other | 454,456 |
| Aug 15, 25 | Jolly Mohanjit | other | 0 |
| Nov 13, 25 | Tincoff John M. III | other | 17,833 |
| Nov 13, 25 | Sengupta Shiladitya | other | 624,432 |
| Aug 15, 25 | Sengupta Shiladitya | other | 0 |
| Nov 13, 25 | Nelabhotla Venkateswarlu | other | 615,149 |
| Aug 15, 25 | Nelabhotla Venkateswarlu | other | 7 |
| Aug 15, 25 | Tincoff John M. III | other | 0 |
Our HIND Coverage
We haven't published any research on HIND yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HIND Report →